|
|||||
|
|
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions,and its associations with clinical outcomes in the ADVANCE trial |
|
| Authors: | Elizabeth Selvin PhD Dan Wang MS John William McEvoy MB BCh BAO Stephen P. Juraschek MD Mariana Lazo MD Pavel Hamet MD Mark E. Cooper MBBS MD Michel Marre MD Bryan Williams MD Stephen Harrap PhD John Chalmers MD Mark Woodward PhD |
| Affiliation: | 1. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland;2. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland;3. Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland School of Medicine, National University of Ireland, Galway Campus, Ireland National Institute for Preventive Cardiology, Galway, Ireland;4. Division of General Medicine, Beth Israel Deaconess Medical Centre/Harvard Medical School, Boston, Massachusetts;5. Department of Medicine, Centre Hospitalier de I'Universite de Montreal (CHUM) | CHUM, Montreal, Quebec, Canada;6. Diabetes Department, Central Clinical School, Monash University, Melbourne, Victoria, Australia;7. Department of Diabetology, Endocrinology, and Nutrition, Assistance Publique-Hôpitaux deParis, Bichat Hospital, France;8. Institute of Cardiovascular Sciences, University College London and National Institute of Health Research University College London Hospitals Biomedical Research Centre, United Kingdom;9. The University of Melbourne and Royal Melbourne Hospital, Victoria, Australia;10. The George Institute for Global Health, University of New South Wales, Sydney, Australia;11. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland The University of Melbourne and Royal Melbourne Hospital, Victoria, Australia The George Institute for Global Health, University of New South Wales, Sydney, Australia The George Institute for Global Health, University of Oxford, Oxford, UK |
| Abstract: | |
| Keywords: | clinical trial diabetes complications glycaemic control randomized trial type 2 diabetes cohort study |